Yield10 Bioscience, Inc.
YTEN · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 50% | 400% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 100% | 100% | -21.7% | – |
| R&D Expenses | $2 | $1 | $2 | $2 |
| G&A Expenses | $2 | $1 | $1 | $1 |
| SG&A Expenses | $2 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | -$0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | -$0 |
| Operating Expenses | $4 | $3 | $3 | $4 |
| Operating Income | -$3 | -$2 | -$3 | -$4 |
| % Margin | -711.8% | -813.3% | -5,411.7% | – |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$3 | -$2 | -$3 | -$4 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$2 | -$3 | -$4 |
| % Margin | -719.6% | -824% | -5,443.3% | – |
| EPS | -5.04 | -4.77 | -6.54 | -9.95 |
| % Growth | -5.7% | 27.1% | 34.3% | – |
| EPS Diluted | -5.04 | -4.77 | -6.54 | -9.95 |
| Weighted Avg Shares Out | 1 | 1 | 0 | 0 |
| Weighted Avg Shares Out Dil | 1 | 1 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$3 | -$2 | -$3 | -$4 |
| % Margin | -698.4% | -791.3% | -5,290% | – |